BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shokoples BG, Paradis P, Schiffrin EL. P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2021;41:186-99. [PMID: 32998520 DOI: 10.1161/ATVBAHA.120.315116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fan J, Ren M, Adhikari BK, Wang H, He Y. The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis. J Inflamm Res 2022;15:3847-58. [PMID: 35836721 DOI: 10.2147/JIR.S370483] [Reference Citation Analysis]
2 Jiang Y, Lin J, Zheng H, Zhu P. The Role of Purinergic Signaling in Heart Transplantation. Front Immunol 2022;13:826943. [DOI: 10.3389/fimmu.2022.826943] [Reference Citation Analysis]
3 Gil B, Smith J, Tang Y, Illes P, Engel T. Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor. Int J Mol Sci 2022;23:2380. [PMID: 35216493 DOI: 10.3390/ijms23042380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang L, Li M, Wang Z, Sun P, Wei S, Zhang C, Wu H, Bai H. Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis. Front Immunol 2021;12:780804. [PMID: 35069552 DOI: 10.3389/fimmu.2021.780804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Fu Z, Lin Q, Xu Z, Zhao Y, Cheng Y, Shi D, Fu W, Yang T, Shi H, Cheng D. P2X7 receptor-specific radioligand 18F-FTTM for atherosclerotic plaque PET imaging. Eur J Nucl Med Mol Imaging 2022. [PMID: 35048153 DOI: 10.1007/s00259-022-05689-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Raffaghello L, Principi E, Baratto S, Panicucci C, Pintus S, Antonini F, Del Zotto G, Benzi A, Bruzzone S, Scudieri P, Minetti C, Gazzerro E, Bruno C. P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular Dystrophy. Pharmaceuticals 2022;15:89. [DOI: 10.3390/ph15010089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu J, Dong E, Zhang Y, Xiao H. The Role of the Inflammasome in Heart Failure. Front Physiol 2021;12:709703. [PMID: 34776995 DOI: 10.3389/fphys.2021.709703] [Reference Citation Analysis]
8 Wu J, Cai W, Du R, Li H, Wang B, Zhou Y, Shen D, Shen H, Lan Y, Chen L, Zheng X, Huang D, Shi G. Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis. Front Mol Biosci 2021;8:768594. [PMID: 34765646 DOI: 10.3389/fmolb.2021.768594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jiang LH, Caseley EA, Muench SP, Roger S. Structural basis for the functional properties of the P2X7 receptor for extracellular ATP. Purinergic Signal 2021;17:331-44. [PMID: 33987781 DOI: 10.1007/s11302-021-09790-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Zhou J, Zhou Z, Liu X, Yin HY, Tang Y, Cao X. P2X7 Receptor-Mediated Inflammation in Cardiovascular Disease. Front Pharmacol 2021;12:654425. [PMID: 33995071 DOI: 10.3389/fphar.2021.654425] [Reference Citation Analysis]